Premium
Functional analysis and classification of homozygous and hypomorphic ABCA4 variants associated with Stargardt macular degeneration
Author(s) -
Curtis Susan B.,
Molday Laurie L.,
Garces Fabian A.,
Molday Robert S.
Publication year - 2020
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/humu.24100
Subject(s) - abca4 , stargardt disease , missense mutation , biology , macular degeneration , genetics , phenotype , medicine , gene , ophthalmology
Abstract Stargardt macular degeneration (Stargardt disease 1 [STGD1]) is caused by mutations in the gene encoding ABCA4, an ATP‐binding cassette protein that transports N ‐retinylidene‐phosphatidylethanolamine ( N ‐Ret‐PE) across photoreceptor membranes. Reduced ABCA4 activity results in retinoid accumulation leading to photoreceptor degeneration. The disease onset and severity vary from severe loss in visual acuity in the first decade to mild visual impairment late in life. We determined the effect of 22 disease‐causing missense mutations on the expression and ATPase activity of ABCA4 in the absence and presence of N ‐Ret‐PE. Three classes were identified that correlated with the disease onset in homozygous STGD1 individuals: Class 1 exhibited reduced ABCA4 expression and ATPase activity that was not stimulated by N ‐Ret‐PE; individuals homozygous for these variants had an early disease onset (≤13 years); Class 2 showed reduced ATPase activity with limited stimulation by N ‐Ret‐PE; these correlated with moderate disease onset (14–40 years); and Class 3 displayed high expression and ATPase activity that was strongly activated by N ‐Ret‐PE; these were associated with late disease onset (>40 years). On the basis of our results, we introduce a functionality index for gauging the effect of missense mutations on STGD1 severity. Our studies support the mild phenotype exhibited by the p.Gly863Ala, p.Asn1868Ile, and p.Gly863Ala/p.Asn1868Ile variants.